VANESSA MERCADO: Open Payments
NPI 1700666500 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,187 in 44 payments from 17 companies in 2025. Trend: 2023 $256 · 2024 $1,228 · 2025 $1,187
Food & beverage: $1,187
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 7 | $190 |
| Novo Nordisk Inc | 5 | $188 |
| Kerecis Limited | 2 | $164 |
| ABBVIE INC. | 8 | $156 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $70 |
| Lilly USA, LLC | 3 | $66 |
| Amgen Inc. | 3 | $62 |
| Smith+Nephew, Inc. | 1 | $60 |
| AstraZeneca Pharmaceuticals LP | 2 | $42 |
| Exact Sciences Corporation | 2 | $37 |
Products named: LEQVIO, Kerecis SurgiClose, Ozempic, VRAYLAR, JARDIANCE, Wegovy, RENASYS TOUCH, OTEZLA.
Industry payments across NV — which companies pay providers there.
